- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05052450
Factors Associated With Mortality, Morbidity and Prognosis in Dementia Patients
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Having applied to the Gulhane Training and Research Hospital Geriatrics Polyclinic Being diagnosed with Alzheimer or Lewy Body Dementia or Vascular Dementia or Fronto-Temporal Dementia or Parkinson Disease Dementia Being at the age of 60 years or older
Exclusion Criteria:
Being under the age of 60 Patients with insufficient recorded data and follow-up for the study Patients who either have diagnosis or follow-up in another center. Patients who have severe dementia that prevents applying for outpatient clinic
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Dementia with Alzheimer
Patients previously diagnosed with Alzheimer disease would be included
|
Patients data were collected throughout the following time
|
|
Dementia with Lewy Body Dementia
Patients previously diagnosed with Lewy Body Dementia would be included
|
Patients data were collected throughout the following time
|
|
Dementia with Fronto-Temporal Dementia
Patients previously diagnosed with Fronto-Temporal Dementia would be included
|
Patients data were collected throughout the following time
|
|
Dementia with Vascular Disease
Patients previously diagnosed with Dementia with Vascular Disease would be included
|
Patients data were collected throughout the following time
|
|
Dementia with Parkinson Disease
Patients previously diagnosed with Dementia with Parkinson Disease would be included
|
Patients data were collected throughout the following time
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: 2 years
|
The event of death occuring during the follow-up period
|
2 years
|
|
Mini-Mental State Examination
Time Frame: 2 years
|
It was performed to assess mental status.
It gives an overall opinion on cognitive domains and tests orientation, registration, attention and calculation, recall, and language.
Total scores on Mini-Mental State Examination range from 0 to 30, higher scores show better cognitive performance.
|
2 years
|
|
Barthel Index
Time Frame: 2 years
|
It was used for assessing physical functioning as a part of the routine geriatric evaluation.where the ten performance items used.
Those items defined as feeding, bathing, grooming, dressing, continence of bowel and bladder, toilet use, transfers (bed to chair and back), mobility (on level surfaces), and climbing stairs.
Each item is scored on this scale, and the sum is obtained by adding the score of each item (range, 0-100; higher scores show better performance)
|
2 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Neurocognitive Disorders
- Parkinsonian Disorders
- Basal Ganglia Diseases
- Movement Disorders
- Synucleinopathies
- Neurodegenerative Diseases
- Tauopathies
- Intracranial Arterial Diseases
- Intracranial Arteriosclerosis
- Leukoencephalopathies
- Dementia
- Alzheimer Disease
- Lewy Body Disease
- Dementia, Vascular
Other Study ID Numbers
- 2021/290
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.